• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸化组蛋白 H3 作为口腔鳞状细胞癌细胞增殖标志物的价值。与 Ki-67 和有丝分裂活性指数的比较研究。

The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index.

机构信息

Oral Histopathology Laboratory, Faculty of Dentistry University of the Republic, Uruguay

出版信息

Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e444-e451. doi: 10.4317/medoral.25420.

DOI:10.4317/medoral.25420
PMID:35975799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445610/
Abstract

BACKGROUND

The Phosphohistone H3 (PHH3) antibody is recognized as a biomarker of cell proliferation, specific for cells in mitosis, of prognostic value in different malignant neoplasms, however it has been poorly studied in oral squamous cell carcinoma (OSCC). The main objective of this study was to evaluate the immunoexpression of the PHH3 in the OSCC, through the correlation with the immunoexpression of Ki-67, the mitotic activity index (MAI), histological grading, clinical-morphological parameters and the rate of survival.

MATERIAL AND METHODS

The study sample consisted of 62 cases of OSCC diagnosed in the Pathological Anatomy Laboratory of the Faculty of Dentistry, University of the Republic (Uruguay). In each of them, an immunohistochemical technique was performed for Ki-67 and PHH3 (serine 10) antibodies. Image J software was used for the MAI and biomarker quantification, defining the percentage of positivity and mitotic figures per 1000 tumor cells.

RESULTS

a significant association was obtained between the expression of PHH3 (p 0.016) and MAI (p 0.031) with survival time. However, no similar relationship was found with Ki-67 (p 0.295). Although it was confirmed a statistical association between histological grade and Ki-67 immunoexpression (p 0.004), PHH3 did not show a similar relationship (p 0.564).

CONCLUSIONS

It was confirmed the role of the PHH3 antibody as a biomarker of mitotic figures in OSCC and as a potential marker of cell proliferation. It is noteworthy that this is one of the first works that evaluates a possible relationship between the expression of this antibody and survival in OSCC.

摘要

背景

磷酸化组蛋白 H3(PHH3)抗体被认为是细胞增殖的生物标志物,对有丝分裂细胞特异,在不同的恶性肿瘤中具有预后价值,但在口腔鳞状细胞癌(OSCC)中研究甚少。本研究的主要目的是通过与 Ki-67、有丝分裂活动指数(MAI)、组织学分级、临床形态学参数和生存率的相关性,评估 PHH3 在 OSCC 中的免疫表达。

材料和方法

研究样本由乌拉圭共和国大学牙科学院病理解剖实验室诊断的 62 例 OSCC 组成。在每例中,均进行了 Ki-67 和 PHH3(丝氨酸 10)抗体的免疫组织化学技术。使用 Image J 软件进行 MAI 和生物标志物定量,定义阳性百分比和每 1000 个肿瘤细胞的有丝分裂数。

结果

PHH3(p=0.016)和 MAI(p=0.031)的表达与生存时间呈显著相关。然而,与 Ki-67 (p=0.295)无类似关系。尽管证实了组织学分级与 Ki-67 免疫表达之间存在统计学关联(p=0.004),但 PHH3 没有显示出类似的关系(p=0.564)。

结论

证实了 PHH3 抗体作为 OSCC 有丝分裂数生物标志物和潜在增殖细胞标志物的作用。值得注意的是,这是评估该抗体表达与 OSCC 生存率之间可能存在关系的首批研究之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/7187642899d8/medoral-27-e444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/7f4e8dbed799/medoral-27-e444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/ed86ee8d46be/medoral-27-e444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/b23d2c064f22/medoral-27-e444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/7187642899d8/medoral-27-e444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/7f4e8dbed799/medoral-27-e444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/ed86ee8d46be/medoral-27-e444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/b23d2c064f22/medoral-27-e444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9445610/7187642899d8/medoral-27-e444-g004.jpg

相似文献

1
The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index.磷酸化组蛋白 H3 作为口腔鳞状细胞癌细胞增殖标志物的价值。与 Ki-67 和有丝分裂活性指数的比较研究。
Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e444-e451. doi: 10.4317/medoral.25420.
2
Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.磷酸化组蛋白H3(PHH3)在默克尔细胞癌中具有预后相关性,但默克尔细胞多瘤病毒是比美国癌症联合委员会(AJCC)临床分期、PHH3、Ki-67或有丝分裂指数更强有力的预后因素。
Pathol Int. 2015 Aug;65(8):404-9. doi: 10.1111/pin.12305. Epub 2015 May 18.
3
Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody.使用磷酸组蛋白 H3(PHH3)抗体提高套细胞淋巴瘤有丝分裂细胞的精确计数。
J Clin Pathol. 2021 Oct;74(10):646-649. doi: 10.1136/jclinpath-2020-206956. Epub 2020 Sep 1.
4
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.早期 luminal 型乳腺癌中利用有丝分裂活性指数、Ki67 和磷酸化组蛋白 H3 表达评估肿瘤增殖。
Histopathology. 2020 Oct;77(4):579-587. doi: 10.1111/his.14185. Epub 2020 Aug 30.
5
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.Ki-67 表达优于有丝分裂计数和新的增殖标志物 PHH3、MCM4 和 mitosin,是厚型皮肤黑色素瘤的预后因素。
BMC Cancer. 2010 Apr 14;10:140. doi: 10.1186/1471-2407-10-140.
6
Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.有丝分裂素和磷酸化组蛋白H3预示着世界卫生组织II级和III级星形细胞瘤患者的生存率更低。
J Clin Pathol. 2016 Jan;69(1):26-34. doi: 10.1136/jclinpath-2015-202983. Epub 2015 Jul 17.
7
Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.通过磷酸化组蛋白H3免疫组织化学测定有丝分裂指数用于滤泡性淋巴瘤的精确分级
Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):579-585. doi: 10.1097/PAI.0000000000000481.
8
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.Ki-67增殖指数而非有丝分裂阈值整合了低级别胶质瘤的分子预后分层。
Oncotarget. 2016 Apr 19;7(16):21190-8. doi: 10.18632/oncotarget.8498.
9
Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.抗磷酸化组蛋白H3抗体免疫染色在脑膜瘤病例有丝分裂计数中的敏感性和实用性。
Brain Tumor Pathol. 2009;26(2):51-7. doi: 10.1007/s10014-009-0249-9. Epub 2009 Oct 27.
10
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.磷酸组蛋白 H3(PHH3)作为脑膜瘤分级中有丝分裂像计数的替代物:PHH3(S10)与 PHH3(S28)抗体的比较。
Virchows Arch. 2019 Jan;474(1):87-96. doi: 10.1007/s00428-018-2458-2. Epub 2018 Sep 29.

引用本文的文献

1
Mitosis - predicting primary tumour and metastatic lymph node behaviour and beyond in OSCC - A pilot study.有丝分裂——预测口腔鳞状细胞癌中原发性肿瘤和转移性淋巴结的行为及其他——一项初步研究
J Oral Maxillofac Pathol. 2024 Oct-Dec;28(4):602-611. doi: 10.4103/jomfp.jomfp_292_24. Epub 2024 Dec 31.
2
Hippo effector, Yorkie, is a tumor suppressor in select squamous epithelia.Hippo 效应因子 Yorkie 是某些鳞状上皮中的肿瘤抑制因子。
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2319666121. doi: 10.1073/pnas.2319666121. Epub 2024 Sep 17.
3
Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.

本文引用的文献

1
Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index.胃肠胰神经内分泌肿瘤增殖标志物 Ki67 和磷酸组蛋白 H3 的数字图像分析:与 Ki67 指数的常规手动热点评估分级相比的准确性。
Appl Immunohistochem Mol Morphol. 2021 Aug 1;29(7):499-505. doi: 10.1097/PAI.0000000000000934.
2
Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma.Ki67 标记指数可预测口腔鳞状细胞癌的临床结局和生存。
J Appl Oral Sci. 2021 Mar 1;29:e20200751. doi: 10.1590/1678-7757-2020-0751. eCollection 2021.
3
在口腔上皮异型增生中,有丝分裂计数和 PHH3 表达的预后意义。
Virchows Arch. 2024 Jan;484(1):47-59. doi: 10.1007/s00428-023-03668-6. Epub 2023 Oct 26.
A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues.
一种用于石蜡包埋组织中 Ki-67 免疫染色的新评价方法。
Virchows Arch. 2021 Jul;479(1):121-131. doi: 10.1007/s00428-020-03010-4. Epub 2021 Jan 19.
4
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.早期 luminal 型乳腺癌中利用有丝分裂活性指数、Ki67 和磷酸化组蛋白 H3 表达评估肿瘤增殖。
Histopathology. 2020 Oct;77(4):579-587. doi: 10.1111/his.14185. Epub 2020 Aug 30.
5
Staging and grading of oral squamous cell carcinoma: An update.口腔鳞状细胞癌的分期和分级:更新。
Oral Oncol. 2020 Aug;107:104799. doi: 10.1016/j.oraloncology.2020.104799. Epub 2020 May 20.
6
Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence.采用多重免疫荧光法评价亚洲三阴性乳腺癌中的磷酸化组蛋白 H3。
Breast Cancer Res Treat. 2019 Nov;178(2):295-305. doi: 10.1007/s10549-019-05396-5. Epub 2019 Aug 13.
7
Pattern-Corrected Mitotic Activity Index (PMAI): A Novel Prognosticator of Oral Squamous Cell Carcinoma.模式校正有丝分裂活性指数(PMAI):口腔鳞状细胞癌的一种新型预后指标。
Turk Patoloji Derg. 2020;36(1):31-38. doi: 10.5146/tjpath.2019.01465.
8
Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders.口腔鳞状细胞癌和口腔潜在恶性疾病中的组蛋白修饰。
Oral Dis. 2020 May;26(4):719-732. doi: 10.1111/odi.13115. Epub 2019 Jul 26.
9
The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count.磷酸组蛋白 H3(PHH3)在滤泡性淋巴瘤分级中的应用:与 Ki-67 和 H&E 有丝分裂计数的比较研究。
Am J Clin Pathol. 2019 May 3;151(6):542-550. doi: 10.1093/ajcp/aqz003.
10
Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.Ki-67是口腔鳞状细胞癌复发和转移的独立预后标志物。
Oncol Lett. 2019 Jan;17(1):974-980. doi: 10.3892/ol.2018.9647. Epub 2018 Oct 31.